Skip to main content
. Author manuscript; available in PMC: 2021 Dec 21.
Published in final edited form as: Anticancer Res. 2021 Dec;41(12):5919–5933. doi: 10.21873/anticanres.15411

Figure 7.

Figure 7.

Schematic diagram of our proposed mechanism of action for diallyl trisulfide (DATS) in TNF-α induced TNBC illustrating proinflammatory genes involved in different signaling pathways that mediate the release of CCL2 in MDA-MB-231 (green color) and MDA-MB-468 (yellow color) TNBC cells induced by TNF-α. DATS can inhibit CCL2, IKBKE, and MAPK8.